Anaya-Esparza L.M., Villagrán-de la Mora Z., Ruvalcaba-Gómez J.M. et al.
F1000Research • Jan 30, 2025
Jose David Vargas-Caicedo, Martha Viviana Roa-Cordero, María Fernanda Romero, José Gabriel López Ortíz, Sandra Milena Leal Pinto
Jose David Vargas-Caicedo, Martha Viviana Roa-Cordero, María Fernanda Romero et al. (2026). Plant-mediated synthesis of silver nanoparticles from Moringa oleifera against ESKAPE pathogens. Microbial Pathogenesis. doi:10.1016/j.micpath.2026.108626
Silver nanoparticles made using plant extracts have attracted attention as potential weapons against drug-resistant bacteria, and this study used Moringa oleifera — commonly known as the Miracle Tree — as the biological agent to synthesise those nanoparticles. The ESKAPE pathogens targeted here are a group of six bacterial species (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) that are responsible for the majority of hospital-acquired infections worldwide and are notorious for resisting standard antibiotics. By using moringa plant material to reduce silver ions into nanoparticles, the researchers avoided harsh industrial chemicals, producing what is called a green synthesis. The study then tested whether these moringa-derived silver nanoparticles could inhibit or kill the ESKAPE organisms in laboratory conditions. Green synthesis using plant extracts is considered promising because the organic compounds naturally present in the plant — such as phenolics and flavonoids — may coat the nanoparticles and contribute additional antimicrobial activity beyond the silver itself. The significance of this work lies in the global crisis of antibiotic resistance: finding new agents that can disrupt these particularly dangerous pathogens is a genuine public health priority. However, because the abstract for this study was not available for review, the specific findings, concentrations tested, and outcomes cannot be confirmed from the source text. What is clear from the title and journal context is that the research sits at the intersection of nanotechnology, plant chemistry, and infectious disease — an area of active investigation. Specific values not reported in abstract.
Population
In vitro study targeting ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species); no human or animal subjects
Dosage
No dosage information available; study involves nanoparticle synthesis and in vitro antimicrobial testing, not a consumable intervention
dosage not specified in abstract
Anaya-Esparza L.M., Villagrán-de la Mora Z., Ruvalcaba-Gómez J.M. et al.
F1000Research • Jan 30, 2025
Ahmed M. El-Shehaby, Mahmoud A. Ibrahim, Nadia H. Mohamed et al.
Scientific Reports (Nature) • Dec 16, 2024
Chen Y, Li P, Xue M et al.
Foods (Basel, Switzerland) • Feb 9, 2026